THE MOUNT VIEW PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: P81089 | FLEETWOOD, FY7 6HP
Showing results 151-200 of 696
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Loperamide hydrochloride | 419 | 35.5K | £887 | +79.9% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 417 | 39.3K | £1.6K | +36.1% ▲ |
| Linagliptin | 401 | 10.3K | £11.6K | -2.1% ▼ |
| Progesterone | 383 | 49.4K | £9.6K | -8.5% ▼ |
| Cyclizine hydrochloride | 381 | 21.6K | £757 | +136.2% ▲ |
| Calcipotriol | 379 | 29.6K | £16.3K | +122.6% ▲ |
| Aclidinium bromide | 377 | 377 | £11.6K | +1,320.7% ▲ |
| Glyceryl trinitrate | 376 | 503 | £918 | +59.0% ▲ |
| Clarithromycin | 376 | 9,605 | £1.9K | +53.2% ▲ |
| Estriol | 372 | 7,003 | £5.2K | +74.8% ▲ |
| Baclofen | 368 | 58.5K | £1.0K | +83.7% ▲ |
| 360 | 3,668 | £1.1K | +44.3% ▲ | |
| Nicorandil | 357 | 22.2K | £3.3K | +148.0% ▲ |
| Sacubitril/valsartan | 353 | 19.8K | £32.4K | +47.4% ▲ |
| Tiotropium bromide | 353 | 7,574 | £8.6K | +16.1% ▲ |
| Nortriptyline | 352 | 21.2K | £1.1K | +142.0% ▲ |
| Vortioxetine | 346 | 8,148 | £7.7K | +398.5% ▲ |
| Umeclidinium bromide | 343 | 343 | £9.0K | +456.4% ▲ |
| Cefalexin | 341 | 12.6K | £929 | +193.2% ▲ |
| 339 | 2,910 | £1.2K | +62.2% ▲ | |
| Nifedipine | 335 | 18.7K | £5.9K | +78.8% ▲ |
| 331 | 9,190 | £3.7K | +328.0% ▲ | |
| Desogestrel | 329 | 60.8K | £2.0K | -17.0% ▼ |
| 327 | 33.3K | £1.2K | +284.1% ▲ | |
| Prochlorperazine maleate | 323 | 11.9K | £938 | +59.8% ▲ |
| Hydroxychloroquine sulfate | 323 | 11.5K | £539 | +66.8% ▲ |
| Metronidazole | 322 | 7,405 | £1.2K | +390.0% ▲ |
| Oxybutynin | 318 | 16.7K | £2.5K | +66.9% ▲ |
| Letrozole | 317 | 9,530 | £844 | +69.8% ▲ |
| Biphasic insulin aspart | 316 | 1,798 | £10.7K | +211.2% ▲ |
| Diltiazem hydrochloride | 310 | 12.1K | £2.0K | +0.9% vs avg |
| Clotrimazole | 305 | 4,479 | £2.4K | +176.4% ▲ |
| 305 | 30.1K | £1.9K | +41.0% ▲ | |
| Enalapril maleate | 302 | 10.6K | £478 | +68.1% ▲ |
| Estradiol with progestogen | 302 | 20.1K | £14.1K | -11.4% ▼ |
| Powder extensively hydrolysed formula (0913101) | 297 | 766.0K | £21.4K | +312.3% ▲ |
| Beclometasone dipropionate | 291 | 298 | £907 | +35.3% ▲ |
| Perindopril erbumine | 288 | 10.1K | £819 | -45.7% ▼ |
| Sulfasalazine | 287 | 40.3K | £7.4K | +120.5% ▲ |
| Clonidine hydrochloride | 286 | 39.1K | £3.8K | +436.1% ▲ |
| Clobetasone butyrate | 286 | 16.9K | £2.5K | +40.1% ▲ |
| Fluticasone furoate | 285 | 325 | £2.5K | +47.1% ▲ |
| Azithromycin | 284 | 4,543 | £928 | +124.0% ▲ |
| Clotrimazole | 284 | 12.5K | £709 | +193.1% ▲ |
| Valproic acid | 282 | 13.7K | £4.0K | +224.1% ▲ |
| Procyclidine hydrochloride | 280 | 14.2K | £2.6K | +97.9% ▲ |
| 276 | 2,823 | £7.5K | +477.1% ▲ | |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 269 | 309 | £4.3K | +137.2% ▲ |
| Docusate sodium | 268 | 20.0K | £1.5K | -27.7% ▼ |
| Etoricoxib | 266 | 7,644 | £1.9K | +230.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.